86 related articles for article (PubMed ID: 8259535)
1. The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionized calcium.
Falcon CR; Cattaneo M; Ghidoni A; Mannucci PM
Thromb Haemost; 1993 Sep; 70(3):389-92. PubMed ID: 8259535
[TBL] [Abstract][Full Text] [Related]
2. Effects of alcohol withdrawal on responses of platelets from alcoholics--a study using platelet-rich plasma from blood anticoagulated with D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone (FPRCH2Cl).
Rand ML; Neiman J; Jakowec DM; Packham MA
Thromb Haemost; 1990 Apr; 63(2):178-82. PubMed ID: 2363118
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility and temporal stability of ADP-induced platelet aggregation: comparison of the anticoagulants sodium citrate and D-phenylalanyl-L-prolyl-L-arginyl-chloromethyl ketone.
Horne WC; Anderson GM; Cohen DJ
Am J Hematol; 1991 Sep; 38(1):48-53. PubMed ID: 1897514
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
Chen SY; Yu BJ; Liang YQ; Lin WD
Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
[TBL] [Abstract][Full Text] [Related]
5. Agglutination of rabbit platelets in plasma by the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
Packham MA; Bryant NL; Guccione MA
Thromb Haemost; 1990 Apr; 63(2):282-5. PubMed ID: 2363129
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
Bode-Böger SM; Böger RH; Galland A; Frölich JC
Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
[TBL] [Abstract][Full Text] [Related]
7. Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents.
Packham MA; Bryant NL; Guccione MA; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1989 Nov; 62(3):968-76. PubMed ID: 2512683
[TBL] [Abstract][Full Text] [Related]
8. [Changes in cytosolic free calcium and thromboxane B2 synthesis in platelets from diabetic subjects].
Cai D; Yu B; Yan T
Zhonghua Yi Xue Za Zhi; 1995 Aug; 75(8):476-8, 510-1. PubMed ID: 7584570
[TBL] [Abstract][Full Text] [Related]
9. Conditions affecting the responses of human platelets to epinephrine.
Lalau Keraly C; Kinlough-Rathbone RL; Packham MA; Suzuki H; Mustard JF
Thromb Haemost; 1988 Oct; 60(2):209-16. PubMed ID: 3217918
[TBL] [Abstract][Full Text] [Related]
10. Effects of MN-9202 on platelet aggregation, 5-HT release, TXB2 synthesis, and calcium mobilization in rabbit platelets in vitro.
Wang LL; Mei QB; Zhao DH; Guo ZA
Acta Pharmacol Sin; 2000 Jul; 21(7):623-6. PubMed ID: 11360670
[TBL] [Abstract][Full Text] [Related]
11. Increased platelet thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Colwell JA
J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
[TBL] [Abstract][Full Text] [Related]
12. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
Stuart MJ; Dusse J; Clark DA; Walenga RW
Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
[TBL] [Abstract][Full Text] [Related]
13. Conditions influencing the interaction of asialo von Willebrand factor with human platelets--the effects of external ionized calcium concentration and the role of arachidonate pathway.
Cattaneo M; Mustard JF; Canciani MT; Richardson M; Federici AB; Mannucci PM
Thromb Haemost; 1988 Oct; 60(2):280-8. PubMed ID: 3146144
[TBL] [Abstract][Full Text] [Related]
14. PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change.
Greco NJ; Tenner TE; Tandon NN; Jamieson GA
Blood; 1990 May; 75(10):1989-90. PubMed ID: 2337670
[TBL] [Abstract][Full Text] [Related]
15. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
[TBL] [Abstract][Full Text] [Related]
16. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
[TBL] [Abstract][Full Text] [Related]
17. Investigations on platelet function in diabetes mellitus.
Kubisz P; Arabi A; Holan J; Cronberg S
Haemostasis; 1984; 14(4):347-53. PubMed ID: 6238882
[TBL] [Abstract][Full Text] [Related]
18. The metabolism of arachidonic acid by platelets in nephrotic syndrome.
Schieppati A; Dodesini P; Benigni A; Massazza M; Mecca G; Remuzzi G; Livio M; de Gaetano G; Rossi EC
Kidney Int; 1984 Apr; 25(4):671-6. PubMed ID: 6434788
[TBL] [Abstract][Full Text] [Related]
19. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
[TBL] [Abstract][Full Text] [Related]
20. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
